Format

Send to

Choose Destination
See comment in PubMed Commons below
Trends Microbiol. 2006 Apr;14(4):190-6. Epub 2006 Feb 24.

Clostridium spores as anti-tumour agents.

Author information

1
Rega Institute for Medical Research, Minderbroedersstraat 10, B-3000 Leuven, Belgium.

Abstract

The successful treatment of cancer remains a huge challenge. Consequently, efforts are being made to develop alternative methods of tumour therapy. One of these is the use of live Clostridium species, based on the observation that obligatory anaerobic bacteria specifically colonize the hypoxic and necrotic regions that are present in solid tumours but normally absent in other parts of the body. Although past results have fuelled scepticism about its clinical use, recent promising findings emphasize the potential of Clostridium-directed tumour therapy. These recent developments are reviewed and the reintroduction of this tumour-targeting protein delivery system into clinical settings is discussed.

PMID:
16500103
DOI:
10.1016/j.tim.2006.02.002
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center